These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25314012)

  • 1. Protein binding of fentanyl and its metabolite nor-fentanyl in human plasma, albumin and α-1 acid glycoprotein.
    Bista SR; Haywood A; Hardy J; Lobb M; Tapuni A; Norris R
    Xenobiotica; 2015 Mar; 45(3):207-12. PubMed ID: 25314012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum protein binding of fentanyl. The effect of postoperative acute phase reaction with elevated alpha 1-acid glycoprotein and methodologic problems in determination by equilibrium dialysis].
    Wiesner G; Taeger K; Peter K
    Anaesthesist; 1996 Apr; 45(4):323-9. PubMed ID: 8702049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma protein binding and distribution of fentanyl, sufentanil, alfentanil and lofentanil in blood.
    Meuldermans WE; Hurkmans RM; Heykants JJ
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):4-19. PubMed ID: 6214227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentration of fentanyl during conversion from intravenous to transdermal administration to patients with chronic cancer pain.
    Nomura M; Inoue K; Matsushita S; Takahari D; Kondoh C; Shitara K; Ura T; Hayashi K; Kojima H; Kamata M; Tatematsu M; Hosoda R; Sawada S; Oka H; Muro K
    Clin J Pain; 2013 Jun; 29(6):487-91. PubMed ID: 23328324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-induced alterations in plasma drug-binding proteins and their influence on drug binding percentages in dogs.
    Ikenoue N; Saitsu Y; Shimoda M; Kokue E
    Vet Q; 2000 Jan; 22(1):43-9. PubMed ID: 10682387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of in vitro drug interactions with karenitecin, a novel, highly lipophilic camptothecin derivative in phase II clinical development.
    Smith JA; Newman RA; Hausheer FH; Madden T
    J Clin Pharmacol; 2003 Sep; 43(9):1008-14. PubMed ID: 12971034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-binding characteristics of voriconazole determined by high-throughput equilibrium dialysis.
    Vanstraelen K; Wauters J; De Loor H; Vercammen I; Annaert P; Lagrou K; Spriet I
    J Pharm Sci; 2014 Aug; 103(8):2565-70. PubMed ID: 24961809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of taxol to human plasma, albumin and alpha 1-acid glycoprotein.
    Kumar GN; Walle UK; Bhalla KN; Walle T
    Res Commun Chem Pathol Pharmacol; 1993 Jun; 80(3):337-44. PubMed ID: 8102493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.
    Holladay JW; Dewey MJ; Michniak BB; Wiltshire H; Halberg DL; Weigl P; Liang Z; Halifax K; Lindup WE; Back DJ
    Drug Metab Dispos; 2001 Mar; 29(3):299-303. PubMed ID: 11181499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fentanyl and alfentanil plasma protein binding in preterm and term neonates.
    Wilson AS; Stiller RL; Davis PJ; Fedel G; Chakravorti S; Israel BA; McGowan FX
    Anesth Analg; 1997 Feb; 84(2):315-8. PubMed ID: 9024020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal fentanyl in cachectic cancer patients.
    Heiskanen T; Mätzke S; Haakana S; Gergov M; Vuori E; Kalso E
    Pain; 2009 Jul; 144(1-2):218-22. PubMed ID: 19442446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
    Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
    Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved cancer pain treatment using combined fentanyl-TTS and tramadol.
    Marinangeli F; Ciccozzi A; Aloisio L; Colangeli A; Paladini A; Bajocco C; Coaccioli S; Varrassi G
    Pain Pract; 2007 Dec; 7(4):307-12. PubMed ID: 17986161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-1-acid glycoprotein. Differences between the two enantiomers are partly due to cooperativity.
    Mazoit JX; Cao LS; Samii K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):109-15. PubMed ID: 8558418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age- and gender-related differences in carbohydrate concentrations of alpha1-acid glycoprotein variants and the effects of glycoforms on their drug-binding capacities.
    Kishino S; Nomura A; Itoh S; Nakagawa T; Takekuma Y; Sugawara M; Furukawa H; Todo S; Miyazaki K
    Eur J Clin Pharmacol; 2002 Dec; 58(9):621-8. PubMed ID: 12483455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo protein binding of clindamycin in sera with normal and elevated alpha 1-acid glycoprotein concentrations.
    Kays MB; White RL; Gatti G; Gambertoglio JG
    Pharmacotherapy; 1992; 12(1):50-5. PubMed ID: 1549539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, validation and application of an HPLC-MS/MS method for the determination of fentanyl and nor-fentanyl in human plasma and saliva.
    Bista SR; Lobb M; Haywood A; Hardy J; Tapuni A; Norris R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():27-33. PubMed ID: 24780703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
    Clemens KE; Klaschik E
    Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.